Drawing for NICHOLS INSTITUTE DIAGNOSTICS

USPTO serial 76314494

NICHOLS INSTITUTE DIAGNOSTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MATTHEWS, AMOS
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NICHOLS INSTITUTE DIAGNOSTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Davis

DAVID J DAVIS BAKER & MCKENZIE LLP130 E RANDOLPH DR STE 3500CHICAGO, IL 60601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic assays and reagents for the treatment, monitoring and diagnosis of disease;diagnostic assays and reagents for clinical and medical laboratory use; reagents for the treatment, monitoring and diagnosis of disease; reagents for clinical and medical laboratory use; diagnostic kits consisting primarily of diagnostic assays, specimen holders, diagnostic preparation agents, and specimen preparation agents for the treatment,monitoring, and diagnosis of disease; diagnostic kits consisting primarily of diagnostic assays, specimen holders, diagnostic preparation agents, and specimen preparation agents for clinical and medical laboratory useACTIVE—
009laboratory analyzers, namely, analyzers for use in assay testing, immunoassay testing,chemiluminescence testing, immunoradiometric testing, immunodiagnostic testing,genetic testing, batch analyzers, washers and washing systems, automated testing, rack systems, luminometers, and radiological testing in the fields of clinical, medical and diagnostic testing; detectors, namely, luminescent and radio immune detectors in the fields of clinical, medical and diagnostic testing, namely, immunoassays in the fields of thyroid function, bone and mineral metabolism, reproduction, growth, hypertension,anemia and adrenal/pituitary function; diagnostic instrumentation, namely, immunoassay analyzers and analyzers for chemiluminescent testing, immunoassay testing, and diagnostic assays; automated testing analyzers namely, analyzers for use in assay testing,immunoassay testing, chemiluminescence testing, immunoradiometric testing,immunodiagnostic testing, genetic testing, batch analyzers, washers and washing systems, rack systems, luminometers and radiological testing in the fields of clinical,medical and diagnostic testing; and computer software for use in diagnostic, laboratory,clinical and medical testing analyzersACTIVE—
010clinical and medical analyzers, namely, immunoassay analyzers in the fields of clinical,medical and diagnostic testing, namely, immunoassays in the fields of thyroid function,bone and mineral metabolism, reproduction, growth, hypertension, anemia and adrenal/pituitary functionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 30, 2007MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 30, 2007ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 12, 2006EX2GSOU EXTENSION 2 GRANTED—
Jul 12, 2006EXT2SOU EXTENSION 2 FILED—
Jul 12, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 12, 2006EX1GSOU EXTENSION 1 GRANTED—
Jan 12, 2006EXT1SOU EXTENSION 1 FILED—
Jan 12, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 12, 2006ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2006REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 12, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 19, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 30, 2005NPUBNOTICE OF PUBLICATION—
Jan 18, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 22, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 18, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 13, 2004ALIEASSIGNED TO LIE—
Sep 9, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 2004MAILPAPER RECEIVED—
Mar 16, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2004ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 29, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2003CFITCASE FILE IN TICRS—
Oct 27, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 27, 2003MAILPAPER RECEIVED—
Apr 24, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 23, 2002MAILPAPER RECEIVED—
Jun 21, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2002MAILPAPER RECEIVED—
Dec 4, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2001DOCKASSIGNED TO EXAMINER—
Nov 20, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance